JULIA P. GREGORY - 20 Dec 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
20 Dec 2021
Transactions value $
-$1,216,440
Form type
4
Filing time
22 Dec 2021, 20:51:33 UTC
Previous filing
24 May 2021
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Options Exercise $283,560 +12,000 $23.63* 12,000 20 Dec 2021 Direct F1
transaction BHVN Common Shares Sale -$1,500,000 -12,000 -100% $125* 0 20 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Employee Stock Option (Right to Buy) Options Exercise $0 -12,000 -100% $0* 0 20 Dec 2021 Common Shares 12,000 $23.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 This option grant was made pursuant to the Issuer's non-employee director compensation policy. The option, representing a right to purchase a total of 36,000 shares, was granted on August 2, 2017, and vested in three equal installments on August 2, 2018, 2019 and 2020.

Remarks:

Exhibit List: Exhibit 24: Power of attorney